206 related articles for article (PubMed ID: 32826317)
1. Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR-Cas that degrades the second messenger cA
Brown S; Gauvin CC; Charbonneau AA; Burman N; Lawrence CM
J Biol Chem; 2020 Oct; 295(44):14963-14972. PubMed ID: 32826317
[TBL] [Abstract][Full Text] [Related]
2. Tetramerisation of the CRISPR ring nuclease Crn3/Csx3 facilitates cyclic oligoadenylate cleavage.
Athukoralage JS; McQuarrie S; Grüschow S; Graham S; Gloster TM; White MF
Elife; 2020 Jun; 9():. PubMed ID: 32597755
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of cyclic oligoadenylate degradation by ancillary Type III CRISPR-Cas ring nucleases.
Molina R; Jensen ALG; Marchena-Hurtado J; López-Méndez B; Stella S; Montoya G
Nucleic Acids Res; 2021 Dec; 49(21):12577-12590. PubMed ID: 34850143
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.
Xia P; Dutta A; Gupta K; Batish M; Parashar V
J Biol Chem; 2022 Feb; 298(2):101591. PubMed ID: 35038453
[TBL] [Abstract][Full Text] [Related]
5. A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.
Han W; Stella S; Zhang Y; Guo T; Sulek K; Peng-Lundgren L; Montoya G; She Q
Nucleic Acids Res; 2018 Nov; 46(19):10319-10330. PubMed ID: 30239876
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems.
Rouillon C; Athukoralage JS; Graham S; Grüschow S; White MF
Methods Enzymol; 2019; 616():191-218. PubMed ID: 30691643
[TBL] [Abstract][Full Text] [Related]
7. An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity.
Athukoralage JS; McMahon SA; Zhang C; Grüschow S; Graham S; Krupovic M; Whitaker RJ; Gloster TM; White MF
Nature; 2020 Jan; 577(7791):572-575. PubMed ID: 31942067
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA
Jia N; Jones R; Yang G; Ouerfelli O; Patel DJ
Mol Cell; 2019 Sep; 75(5):944-956.e6. PubMed ID: 31326273
[TBL] [Abstract][Full Text] [Related]
9. CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.
Grüschow S; McQuarrie S; Ackermann K; McMahon S; Bode BE; Gloster TM; White MF
Nucleic Acids Res; 2024 Apr; 52(6):2761-2775. PubMed ID: 38471818
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cyclic oligoadenylate synthesis by the
Nasef M; Muffly MC; Beckman AB; Rowe SJ; Walker FC; Hatoum-Aslan A; Dunkle JA
RNA; 2019 Aug; 25(8):948-962. PubMed ID: 31076459
[TBL] [Abstract][Full Text] [Related]
11. Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6.
Garcia-Doval C; Schwede F; Berk C; Rostøl JT; Niewoehner O; Tejero O; Hall J; Marraffini LA; Jinek M
Nat Commun; 2020 Mar; 11(1):1596. PubMed ID: 32221291
[TBL] [Abstract][Full Text] [Related]
12. Ring nucleases deactivate type III CRISPR ribonucleases by degrading cyclic oligoadenylate.
Athukoralage JS; Rouillon C; Graham S; Grüschow S; White MF
Nature; 2018 Oct; 562(7726):277-280. PubMed ID: 30232454
[TBL] [Abstract][Full Text] [Related]
13. A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator.
Athukoralage JS; Graham S; Grüschow S; Rouillon C; White MF
J Mol Biol; 2019 Jul; 431(15):2894-2899. PubMed ID: 31071326
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of cyclic tetra-oligoadenylate processing by small standalone CRISPR-Cas ring nucleases.
Molina R; Garcia-Martin R; López-Méndez B; Jensen ALG; Ciges-Tomas JR; Marchena-Hurtado J; Stella S; Montoya G
Nucleic Acids Res; 2022 Oct; 50(19):11199-11213. PubMed ID: 36271789
[TBL] [Abstract][Full Text] [Related]
15. Cyclic Tetra-Adenylate (cA
Charbonneau AA; Eckert DM; Gauvin CC; Lintner NG; Lawrence CM
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944496
[TBL] [Abstract][Full Text] [Related]
16. Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
Niewoehner O; Garcia-Doval C; Rostøl JT; Berk C; Schwede F; Bigler L; Hall J; Marraffini LA; Jinek M
Nature; 2017 Aug; 548(7669):543-548. PubMed ID: 28722012
[TBL] [Abstract][Full Text] [Related]
17. A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.
Kazlauskiene M; Kostiuk G; Venclovas Č; Tamulaitis G; Siksnys V
Science; 2017 Aug; 357(6351):605-609. PubMed ID: 28663439
[TBL] [Abstract][Full Text] [Related]
18. Recognition of a pseudo-symmetric RNA tetranucleotide by Csx3, a new member of the CRISPR associated Rossmann fold superfamily.
Topuzlu E; Lawrence CM
RNA Biol; 2016; 13(2):254-7. PubMed ID: 26727591
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Oligonucleotide Signaling Mediated by CRISPR-Associated Polymerases Solves Two Puzzles but Leaves an Enigma.
Koonin EV; Makarova KS
ACS Chem Biol; 2018 Feb; 13(2):309-312. PubMed ID: 28937734
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic properties of CARF-domain proteins in
Ding J; Schuergers N; Baehre H; Wilde A
Front Microbiol; 2022; 13():1046388. PubMed ID: 36419420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
